The lowering of the price target from $41 to $33 by Citigroup suggests a less favorable view on Helmerich & Payne's future performance, which could lead to a negative short-term impact on the stock price. The Neutral rating indicates no strong buy or sell recommendation, but the reduced price target may influence investor sentiment negatively.